Is Sutro Biopharma, Inc. STRO stock halal to invest in?

No, as of February 2026, Sutro Biopharma, Inc. stock (STRO) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Sutro Biopharma, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Sutro Biopharma, Inc. and alternative halal stock options within the Tabadulat app.

How often is Sutro Biopharma, Inc. STRO reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Sutro Biopharma, Inc. STRO monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Sutro Biopharma, Inc. STRO pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Sutro Biopharma, Inc. stock (STRO) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Sutro Biopharma, Inc. STRO pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Sutro Biopharma, Inc. stock (STRO) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

No, as of February 2026, Sutro Biopharma, Inc. stock (STRO) does not pass the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Sutro Biopharma, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

STRO

About

Sutro Biopharma, Inc.

STRO

Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and manufacturing of next-generation protein therapeutics for oncology and immune-related diseases. Its proprietary cell-free protein synthesis platform, XpressCF, enables precise engineering of complex biologic drugs, including antibody-drug conjugates and targeted protein therapies. Key pipeline candidates include STRO-001 for multiple myeloma and non-Hodgkin lymphoma, and STRO-002 for ovarian and endometrial cancers, alongside early-stage programs addressing high unmet medical needs in cancer and autoimmune disorders. Operating in the biotechnology industry within the healthcare sector, the company is headquartered at 111 Oyster Point Boulevard in South San Francisco, California, with 178 employees led by CEO Ms. Jane Chung R.Ph. Sutro Biopharma, Inc. plays a significant role in the financial markets as a specialized biotech issuer, where its valuation reflects clinical trial advancements, regulatory approvals, and strategic partnerships characteristic of innovative drug development enterprises.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

178

Website:

https://www.sutrobio.com

STRO

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Sutro Biopharma, Inc.

About

Sutro Biopharma, Inc.

STRO

Frequently asked questions

Is Sutro Biopharma, Inc. STRO stock halal to invest in?

How often is Sutro Biopharma, Inc. STRO reviewed for Shariah compliance?

Does Sutro Biopharma, Inc. STRO pass the AAOIFI Non Permissible Income criteria?

Does Sutro Biopharma, Inc. STRO pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Sutro Biopharma, Inc. STRO stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.